interleukin 7 (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
95
Structured Review
R&D Systems
interleukin 7
Interleukin 7, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 206 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+interleukin+7/Recombinant+Human+IL-7+Protein/us12466878-637-0-3
Average 95 stars, based on 206 article reviews
Interleukin 7, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 206 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+interleukin+7/Recombinant+Human+IL-7+Protein/us12466878-637-0-3
Average 95 stars, based on 206 article reviews
interleukin 7 - by Bioz Stars,
2026-10
95/100 stars
Images
Related Articles
Derivative Assay:Article Title: Hypoxic, glycolytic metabolism is a vulnerability of B-acute lymphoblastic leukemia-initiating cells Article Snippet: Human cell lines were obtained from the ATCC. .. Patient derived leukemia cells were cultured on MS5 stromal cells in the presence of 50 ng/mL recombinant human stem cell factor (SCF), 50 ng/mL recombinant human thrombopoietin (TPO), 10 ng/mL recombinant human FLT3 ligand (FLT3L), and 10 ng/mL Article Title: Single-cell analysis uncovers mechanisms of plasticity in leukemia initiating cells Article Snippet: .. Patient derived leukemia cells were cultured on MS5 stromal cells in the presence of 50 ng/ml recombinant human stem cell factor (SCF), 50 ng/ml recombinant human thrombopoietin (TPO), 10 ng/ml recombinant human FLT3 ligand (FLT3L), and 10 ng/ml Cell Culture:Article Title: Hypoxic, glycolytic metabolism is a vulnerability of B-acute lymphoblastic leukemia-initiating cells Article Snippet: Human cell lines were obtained from the ATCC. .. Patient derived leukemia cells were cultured on MS5 stromal cells in the presence of 50 ng/mL recombinant human stem cell factor (SCF), 50 ng/mL recombinant human thrombopoietin (TPO), 10 ng/mL recombinant human FLT3 ligand (FLT3L), and 10 ng/mL Article Title: Concomitant inhibition of the thioredoxin system and nonhomologous DNA repair potently sensitizes Philadelphia‐positive lymphoid leukemia to tyrosine kinase inhibitors Article Snippet: For frozen samples whose viability after thawing was less than 90%, dead cells were discarded through centrifugation in the Lymphoprep (STEMCELL Technologies) gradient. .. Cells were seeded onto a 96‐well U‐bottom plate at 0.5 × 10 6 cells/mL in a final volume of 200 μL of SFEM II medium (Gibco), supplemented with 20% FBS (Gibco), 20 ng/mL recombinant human interleukin‐3 and 10 ng/mL Article Title: Effects of hypoxia on antigen presentation and T cell-based immune recognition of HPV16-transformed cells Article Snippet: .. PBMCs were thawed and one T cell culture per antigen stimulation was set up with 1–2 × 10 6 cells/well in 24-well plates in T cell medium (RPMI-1640 with 10% FBS, 2 mM L-glutamine, 10 mM HEPES, and 1% P/S) supplemented with 10 ng/ml Article Title: Single-cell analysis uncovers mechanisms of plasticity in leukemia initiating cells Article Snippet: .. Patient derived leukemia cells were cultured on MS5 stromal cells in the presence of 50 ng/ml recombinant human stem cell factor (SCF), 50 ng/ml recombinant human thrombopoietin (TPO), 10 ng/ml recombinant human FLT3 ligand (FLT3L), and 10 ng/ml Recombinant:Article Title: Hypoxic, glycolytic metabolism is a vulnerability of B-acute lymphoblastic leukemia-initiating cells Article Snippet: Human cell lines were obtained from the ATCC. .. Patient derived leukemia cells were cultured on MS5 stromal cells in the presence of 50 ng/mL recombinant human stem cell factor (SCF), 50 ng/mL recombinant human thrombopoietin (TPO), 10 ng/mL recombinant human FLT3 ligand (FLT3L), and 10 ng/mL Article Title: Hypoxic, glycolytic metabolism is a vulnerability of B-acute lymphoblastic leukemia-initiating cells Article Snippet: Recombinant human thrombopoietin , R and D Systems , 288-TP-005. .. Article Title: Concomitant inhibition of the thioredoxin system and nonhomologous DNA repair potently sensitizes Philadelphia‐positive lymphoid leukemia to tyrosine kinase inhibitors Article Snippet: For frozen samples whose viability after thawing was less than 90%, dead cells were discarded through centrifugation in the Lymphoprep (STEMCELL Technologies) gradient. .. Cells were seeded onto a 96‐well U‐bottom plate at 0.5 × 10 6 cells/mL in a final volume of 200 μL of SFEM II medium (Gibco), supplemented with 20% FBS (Gibco), 20 ng/mL recombinant human interleukin‐3 and 10 ng/mL Article Title: Effects of hypoxia on antigen presentation and T cell-based immune recognition of HPV16-transformed cells Article Snippet: .. PBMCs were thawed and one T cell culture per antigen stimulation was set up with 1–2 × 10 6 cells/well in 24-well plates in T cell medium (RPMI-1640 with 10% FBS, 2 mM L-glutamine, 10 mM HEPES, and 1% P/S) supplemented with 10 ng/ml Article Title: Single-cell analysis uncovers mechanisms of plasticity in leukemia initiating cells Article Snippet: .. Patient derived leukemia cells were cultured on MS5 stromal cells in the presence of 50 ng/ml recombinant human stem cell factor (SCF), 50 ng/ml recombinant human thrombopoietin (TPO), 10 ng/ml recombinant human FLT3 ligand (FLT3L), and 10 ng/ml Article Title: PEBP 1 suppresses HIV transcription and induces latency by inactivating MAPK / NF ‐κB signaling Article Snippet: Naive CD4 + T cells were further purified from peripheral blood mononuclear cells by negative selection according to the manufacturer's instructions (Thermo). .. The Naive CD4 + T cells were maintained in serum‐free medium supplemented with 1% penicillin‐streptomycin and 5 ng/ml recombinant human interleukin‐2 (R&D) and 10 ng/ml Article Title: FKBP3 Induces Human Immunodeficiency Virus Type 1 Latency by Recruiting Histone Deacetylase 1/2 to the Viral Long Terminal Repeat Article Snippet: Naive CD4 + T cells were further purified from peripheral blood mononuclear cells by negative selection according to the manufacturer's instructions (Thermo Fisher). .. The naive CD4 + T cells were maintained in serum-free medium supplemented with 1% penicillin-streptomycin, 5 ng/ml recombinant human interleukin-2 (R&D Systems), and 10 ng/ml Flow Cytometry:Article Title: Concomitant inhibition of the thioredoxin system and nonhomologous DNA repair potently sensitizes Philadelphia‐positive lymphoid leukemia to tyrosine kinase inhibitors Article Snippet: For frozen samples whose viability after thawing was less than 90%, dead cells were discarded through centrifugation in the Lymphoprep (STEMCELL Technologies) gradient. .. Cells were seeded onto a 96‐well U‐bottom plate at 0.5 × 10 6 cells/mL in a final volume of 200 μL of SFEM II medium (Gibco), supplemented with 20% FBS (Gibco), 20 ng/mL recombinant human interleukin‐3 and 10 ng/mL Staining:Article Title: Concomitant inhibition of the thioredoxin system and nonhomologous DNA repair potently sensitizes Philadelphia‐positive lymphoid leukemia to tyrosine kinase inhibitors Article Snippet: For frozen samples whose viability after thawing was less than 90%, dead cells were discarded through centrifugation in the Lymphoprep (STEMCELL Technologies) gradient. .. Cells were seeded onto a 96‐well U‐bottom plate at 0.5 × 10 6 cells/mL in a final volume of 200 μL of SFEM II medium (Gibco), supplemented with 20% FBS (Gibco), 20 ng/mL recombinant human interleukin‐3 and 10 ng/mL Concentration Assay:Article Title: Concomitant inhibition of the thioredoxin system and nonhomologous DNA repair potently sensitizes Philadelphia‐positive lymphoid leukemia to tyrosine kinase inhibitors Article Snippet: For frozen samples whose viability after thawing was less than 90%, dead cells were discarded through centrifugation in the Lymphoprep (STEMCELL Technologies) gradient. .. Cells were seeded onto a 96‐well U‐bottom plate at 0.5 × 10 6 cells/mL in a final volume of 200 μL of SFEM II medium (Gibco), supplemented with 20% FBS (Gibco), 20 ng/mL recombinant human interleukin‐3 and 10 ng/mL |